Evidence map›Paper›PMID 39157675›Full record

ArticleJTO clinical and research reports2024

Outcomes of Resected Lung Cancer Diagnosed Through Screening and Incidental Pulmonary Nodule Programs in a Mississippi Delta Cohort.

Olawale Akinbobola, Wei Liao, Meredith A Ray, Carrie Fehnel, Jordan Goss, Talat Qureshi, Andrea Saulsberry, Kourtney Dortch, Matthew P Smeltzer, Raymond U Osarogiagbon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JTO clinical and research reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Olawale AkinbobolaThoracic Oncology Research Group, Baptist Cancer Center, Memphis, Tennessee.
Wei LiaoThoracic Oncology Research Group, Baptist Cancer Center, Memphis, Tennessee.
Meredith A RaySchool of Public Health, University of Memphis, Memphis, Tennessee.
Carrie FehnelThoracic Oncology Research Group, Baptist Cancer Center, Memphis, Tennessee.
Jordan GossThoracic Oncology Research Group, Baptist Cancer Center, Memphis, Tennessee.
Talat QureshiThoracic Oncology Research Group, Baptist Cancer Center, Memphis, Tennessee.
Andrea SaulsberryThoracic Oncology Research Group, Baptist Cancer Center, Memphis, Tennessee.
Kourtney DortchThoracic Oncology Research Group, Baptist Cancer Center, Memphis, Tennessee.
Matthew P SmeltzerSchool of Public Health, University of Memphis, Memphis, Tennessee.
Raymond U OsarogiagbonThoracic Oncology Research Group, Baptist Cancer Center, Memphis, Tennessee.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Early lung cancer detection programs improve surgical resection rates and survival but may skew toward more indolent cancers. Methods: Hypothesizing that differences in stage-stratified survival indicate differences in biological aggressiveness and possible length-time and overdiagnosis bias, we assessed a cohort who had curative-intent resection, categorized by diagnostic pathways: screening, incidental pulmonary nodule program, and non-program based. Survival was analyzed using Kaplan-Meier plots, log-rank tests, and Cox regression, comparing aggregate and stage-stratified survival across cohorts with Tukey's method for multiple testing. Results: Of 1588 patients, 111 patients (7%), 357 patients (22.5%), and 1120 patients (70.5%) were diagnosed through screening, pulmonary nodule, and non-program-based pathways; 0% versus 9% versus 6% were older than 80 years ( Conclusions: Neither length-time nor overdiagnosis bias was evident in NSCLC diagnosed through screening or incidental pulmonary nodule programs.

Indexed as

Early detectionLength-time biasOverdiagnosis biasSurvival

Identifiers

PMID39157675
PMCPMC11327436

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.